Trastuzumab-related cardiotoxicity in the herceptin adjuvant trial

J Clin Oncol. 2008 Apr 20;26(12):2052-3; author reply 2053-4. doi: 10.1200/JCO.2007.15.5044.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Cardiovascular Diseases / chemically induced*
  • Chemotherapy, Adjuvant
  • Heart Failure / chemically induced
  • Humans
  • Middle Aged
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Trastuzumab